|
|
|
Insider
Information: |
Lanchbury Jerry S |
Relationship: |
Chief Scientific Officer |
City: |
Salt Lake City |
State: |
UT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
264,324 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,016,014 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
264,324 |
|
|
Total
Value |
$6,016,014 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2020-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,800 |
226,308 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2020-09-25 |
4 |
D |
$12.44 |
$121,390 |
D/D |
(9,758) |
216,550 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2020-09-26 |
4 |
D |
$12.44 |
$45,120 |
D/D |
(3,627) |
212,923 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2020-09-30 |
4 |
D |
$13.04 |
$72,294 |
D/D |
(5,544) |
207,379 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
39,196 |
246,575 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-02-16 |
4 |
AS |
$29.71 |
$2,377,048 |
D/D |
(80,000) |
246,575 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-02-16 |
4 |
OE |
$18.00 |
$1,440,000 |
D/D |
80,000 |
252,130 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,347 |
265,922 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-04-27 |
4 |
OE |
$19.47 |
$778,800 |
D/D |
40,000 |
305,922 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-04-27 |
4 |
AS |
$31.47 |
$1,258,800 |
D/D |
(40,000) |
265,922 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-05-04 |
4 |
OE |
$19.47 |
$376,939 |
D/D |
19,360 |
285,282 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-05-04 |
4 |
AS |
$31.97 |
$618,949 |
D/D |
(19,360) |
265,922 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-06-25 |
4 |
OE |
$19.47 |
$973,500 |
D/D |
50,000 |
294,562 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-06-25 |
4 |
AS |
$31.61 |
$2,664,216 |
D/D |
(83,372) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-06-28 |
4 |
AS |
$32.23 |
$220,608 |
D/D |
(6,812) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-06-28 |
4 |
OE |
$19.47 |
$173,795 |
D/D |
6,812 |
233,498 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-07 |
4 |
OE |
$26.49 |
$855,839 |
D/D |
32,308 |
234,434 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-07 |
4 |
AS |
$31.99 |
$1,042,660 |
D/D |
(32,308) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-09 |
4 |
OE |
$19.47 |
$1,200,302 |
D/D |
50,000 |
250,242 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-09 |
4 |
AS |
$32.29 |
$1,631,037 |
D/D |
(50,000) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-12 |
4 |
OE |
$26.49 |
$1,324,500 |
D/D |
50,000 |
245,845 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-12 |
4 |
AS |
$33.55 |
$1,677,506 |
D/D |
(50,000) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-13 |
4 |
AS |
$33.69 |
$1,460,768 |
D/D |
(43,295) |
232,550 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-07-13 |
4 |
OE |
$26.49 |
$1,146,885 |
D/D |
43,295 |
272,550 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
|
2021-08-03 |
4 |
OE |
$23.98 |
$1,245,210 |
D/D |
50,000 |
236,720 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|